Aurobindo Pharma arm gets CDSCO marketing nod for Bevqolva

Aurobindo Pharma said the Central Drugs Standard Control Organization (CDSCO) has granted marketing authorization under Form CT 23 for the bevacizumab biosimilar for metastatic carcinoma of the colon or rectum.








